{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:52:34Z","timestamp":1769075554866,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.085","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T17:06:52Z","timestamp":1328720812000},"page":"2535-2542","source":"Crossref","is-referenced-by-count":22,"title":["Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]"],"prefix":"10.1016","volume":"30","author":[{"given":"Christian","family":"Savard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-\u00c8ve","family":"Lalibert\u00e9-Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Babin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00e8ne","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Andr\u00e9e","family":"Forget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Majeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9jean","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2012.01.085_bib0005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/08830180802295765","article-title":"Development of a vaccine against pandemic influenza viruses: current status and perspectives","volume":"27","author":"Ilyinskii","year":"2008","journal-title":"Int Rev Immunol"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2012.01.085_bib0010","doi-asserted-by":"crossref","first-page":"D17","DOI":"10.1016\/j.vaccine.2008.07.048","article-title":"Efficacy and effectiveness of influenza vaccination","volume":"26","author":"Nichol","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0015","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JVI.69.4.2075-2081.1995","article-title":"Virus-neutralizing antibodies of immunoglobulin G [IgG] but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice","volume":"69","author":"Palladino","year":"1995","journal-title":"J Virol"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2012.01.085_bib0020","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1016\/j.vaccine.2008.07.043","article-title":"Correlates of protection: novel generations of influenza vaccines","volume":"26","author":"Rimmelzwaan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.085_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/JB.89.1.170-174.1965","article-title":"Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/14787210.1.4.627","article-title":"Control of influenza virus infection by immunity to conserved viral features","volume":"1","author":"Epstein","year":"2003","journal-title":"Expert Rev Antiinfect Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2012.01.085_bib0040","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-70-8-2111","article-title":"Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses","volume":"70","author":"Altmuller","year":"1989","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0045","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.64.4.1487-1497.1990","article-title":"Evolution of the nucleoprotein gene of influenza A virus","volume":"64","author":"Gorman","year":"1990","journal-title":"J Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2012.01.085_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01378629","article-title":"Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages","volume":"131","author":"Scholtissek","year":"1993","journal-title":"Arch Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0055","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/JVI.67.5.2723-2729.1993","article-title":"Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990","volume":"67","author":"Shu","year":"1993","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1084\/jem.160.2.552","article-title":"The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells","volume":"160","author":"Townsend","year":"1984","journal-title":"J Exp Med"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2012.01.085_bib0065","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1099\/0022-1317-67-4-719","article-title":"Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes","volume":"67","author":"McMichael","year":"1986","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","article-title":"Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses","volume":"12","author":"Chen","year":"2000","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.vaccine.2012.01.085_bib0080","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.190.9.1319","article-title":"Selective expansion of cross-reactive CD8[+] memory T cells by viral variants","volume":"190","author":"Haanen","year":"1999","journal-title":"J Exp Med"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.01.085_bib0085","first-page":"417","article-title":"Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo","volume":"58","author":"Taylor","year":"1986","journal-title":"Immunology"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2012.01.085_bib0090","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/S0264-410X(02)00355-9","article-title":"CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein","volume":"20","author":"Gschoesser","year":"2002","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-3083.1978.tb00536.x","article-title":"The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen","volume":"8","author":"Yap","year":"1978","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.085_bib0100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4049\/jimmunol.126.3.1042","article-title":"Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia","volume":"126","author":"Wells","year":"1981","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.085_bib0105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.160.3.814","article-title":"In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific","volume":"160","author":"Lukacher","year":"1984","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.085_bib0110","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.158.3.1222","article-title":"Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice","volume":"158","author":"Epstein","year":"1997","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.01.085_bib0115","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","article-title":"Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA","volume":"72","author":"Ulmer","year":"1998","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.01.085_bib0120","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0125","first-page":"202","article-title":"Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection","volume":"71","author":"Tite","year":"1990","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.vaccine.2012.01.085_bib0130","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4049\/jimmunol.156.10.3892","article-title":"Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein","volume":"156","author":"Tamura","year":"1996","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.01.085_bib0135","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00705-010-0756-3","article-title":"Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein","volume":"155","author":"Guo","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2007.01.011","article-title":"Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization","volume":"363","author":"Denis","year":"2007","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.085_bib0145","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/JVI.01720-06","article-title":"Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells","volume":"81","author":"Leclerc","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/JVI.01811-07","article-title":"Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation","volume":"82","author":"Lacasse","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1742-4658.2005.05033.x","article-title":"Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein","volume":"273","author":"Tremblay","year":"2006","journal-title":"FEBS J"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2012.01.085_bib0160","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus [PapMV] vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.085_bib0165","doi-asserted-by":"crossref","first-page":"e21522","DOI":"10.1371\/journal.pone.0021522","article-title":"Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles","volume":"6","author":"Savard","year":"2011","journal-title":"Plos One"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0170","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.94.5.1663","article-title":"\u201cPeptabody\u201d: a new type of high avidity binding protein","volume":"94","author":"Terskikh","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jbiotec.2006.10.013","article-title":"High avidity binding of engineered papaya mosaic virus virus-like particles to resting spores of Plasmodiophora brassicae","volume":"128","author":"Morin","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2012.01.085_bib0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1477-5956-6-31","article-title":"Label-free detection of biomolecular interactions in real time with a nano-porous silicon-based detection method","volume":"6","author":"Latterich","year":"2008","journal-title":"Proteome Sci"},{"key":"10.1016\/j.vaccine.2012.01.085_bib0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74067-0","article-title":"A neurotropic strain of human influenza virus","volume":"1","author":"Stuart-Harris","year":"1939","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2012.01.085_bib0190","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds","volume":"11","author":"Abed","year":"2006","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0195","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A [H1N1] viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5102","key":"10.1016\/j.vaccine.2012.01.085_bib0200","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0205","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/JVI.72.2.1491-1496.1998","article-title":"Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus","volume":"72","author":"Macklin","year":"1998","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2012.01.085_bib0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3201\/eid0805.010476","article-title":"DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice","volume":"8","author":"Epstein","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.01.085_bib0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jviromet.2008.08.011","article-title":"Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice","volume":"154","author":"Luo","year":"2008","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-3083.1987.tb01042.x","article-title":"The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants","volume":"25","author":"Andrew","year":"1987","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0264-410X(91)90055-B","article-title":"Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens","volume":"9","author":"Webster","year":"1991","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2012.01.085_bib0230","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.vaccine.2004.02.040","article-title":"Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus","volume":"22","author":"Wesley","year":"2004","journal-title":"Vaccine"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2012.01.085_bib0235","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0240","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00705-005-0676-9","article-title":"Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses","volume":"151","author":"Altstein","year":"2006","journal-title":"Arch Virol"},{"issue":"39\u201340","key":"10.1016\/j.vaccine.2012.01.085_bib0245","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2007.07.035","article-title":"Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein","volume":"25","author":"Roy","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.01.085_bib0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/CVI.00451-08","article-title":"Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus","volume":"16","author":"Barefoot","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.01.085_bib0255","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-68-2-433","article-title":"Purified influenza virus nucleoprotein protects mice from lethal infection","volume":"68","author":"Wraith","year":"1987","journal-title":"J Gen Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2012.01.085_bib0260","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"issue":"5138","key":"10.1016\/j.vaccine.2012.01.085_bib0270","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2012.01.085_bib0275","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.01.085_bib0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI11849","article-title":"Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies","volume":"108","author":"Chackerian","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2012.01.085_bib0290","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1099\/0022-1317-70-9-2439","article-title":"The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies","volume":"70","author":"Hocart","year":"1989","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.01.085_bib0295","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.4049\/jimmunol.179.9.6153","article-title":"Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes","volume":"179","author":"Zheng","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.085_bib0300","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1099\/0022-1317-71-5-1169","article-title":"Characterization and immunological properties of influenza A virus nucleoprotein [NP]: cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection","volume":"71","author":"Stitz","year":"1990","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.085_bib0305","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.160.1.322","article-title":"Mechanism of protective immunity against influenza virus infection in mice without antibodies","volume":"160","author":"Epstein","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.01.085_bib0310","first-page":"75","article-title":"Cytotoxic T lymphocytes specific for influenza virus","volume":"189","author":"McMichael","year":"1994","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T12:12:06Z","timestamp":1686744726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":62,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12001466"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}